Early Life
Seo Jung-jin was born on October 23, 1957, in Cheongju, South Korea. He graduated from Jemulpo High School in Incheon and earned a Bachelor's degree in Industrial Engineering and a Master of Business Administration from Konkuk University.
Rise to Success
Seo began his career at Samsung Electronics and later worked as a consultant for Daewoo Motors. In 1999, after the Asian financial crisis, he founded Nexol, which later became Celltrion, with colleagues from Daewoo Motors. His vision was to capitalize on the potential of biosimilars, lower-cost versions of biologic drugs. Celltrion focused on manufacturing drugs for other companies initially. Seo's strategic vision led to a shift towards biosimilars. Celltrion received approval from EMA and FDA for the world's first mAb biosimilar, Remsima® (INFLECTRA®).
Key Business Strategies
Seo's key strategy was to focus on biosimilars, offering lower-cost alternatives to existing biologic drugs. He also aimed to meet global regulations from the beginning, which facilitated the company's international expansion. In December 2023, marketing subsidiary Celltrion Healthcare was merged with Celltrion.
Philanthropy
Information regarding Seo Jung-jin's specific philanthropic contributions or amounts could not be found in the current search results.